Steward Partners Investment Advisory’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-110
| Closed | -$7K | – | 3522 |
|
|
2022
Q3 | $7K | Hold |
110
| – | – | ﹤0.01% | 2673 |
|
|
2022
Q2 | $4K | Sell |
110
-65
| -37% | -$1.9K | ﹤0.01% | 2889 |
|
|
2022
Q1 | $6K | Hold |
175
| – | – | ﹤0.01% | 2862 |
|
|
2021
Q4 | $5K | Hold |
175
| – | – | ﹤0.01% | 2857 |
|
|
2021
Q3 | $4K | Sell |
175
-50
| -22% | -$1.47K | ﹤0.01% | 2894 |
|
|
2021
Q2 | $8K | Sell |
225
-400
| -64% | -$15.6K | ﹤0.01% | 6339 |
|
|
2021
Q1 | $25.5K | Sell |
625
-355
| -36% | -$16.3K | ﹤0.01% | 2356 |
|
|
2020
Q4 | $42K | Sell |
980
-256
| -21% | -$12.6K | ﹤0.01% | 1747 |
|
|
2020
Q3 | $68K | Buy |
1,236
+263
| +27% | +$16.7K | ﹤0.01% | 1371 |
|
|
2020
Q2 | $61K | Buy |
973
+90
| +10% | +$6.17K | ﹤0.01% | 1341 |
|
|
2020
Q1 | $45K | Buy |
883
+338
| +62% | +$22.6K | ﹤0.01% | 1307 |
|
|
2019
Q4 | $43K | Hold |
545
| – | – | ﹤0.01% | 1469 |
|
|
2019
Q3 | $26K | Buy |
545
+25
| +5% | +$1.3K | ﹤0.01% | 1638 |
|
|
2019
Q2 | $27K | Buy |
+520
| New | +$29.9K | ﹤0.01% | 1594 |
|
|
2018
Q4 | – | Sell |
-355
| Closed | -$13K | – | 2360 |
|
|
2018
Q3 | $13K | Hold |
355
| – | – | ﹤0.01% | 1785 |
|
|
2018
Q2 | $16K | Buy |
355
+15
| +4% | +$683 | ﹤0.01% | 1563 |
|
|
2018
Q1 | $16K | Sell |
340
-377
| -53% | -$21K | ﹤0.01% | 1424 |
|
|
2017
Q4 | $28K | Hold |
717
| – | – | ﹤0.01% | 1013 |
|
|
2017
Q3 | $22K | Hold |
717
| – | – | ﹤0.01% | 917 |
|
|
2017
Q2 | $19K | Buy |
717
+331
| +86% | +$9.85K | ﹤0.01% | 887 |
|
|
2017
Q1 | $14K | Buy |
+386
| New | +$9.72K | ﹤0.01% | 859 |
|
Other funds holding GBT
Steward Partners Investment Advisory's GBT Position: Q4 2022 in Review
Steward Partners Investment Advisory sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 110 shares — an estimated $7K sold.
Steward Partners Investment Advisory first reported a position in GBT in Q1 2017 and held it in 21 quarters. The position peaked at $68K in Q3 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Steward Partners Investment Advisory reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Steward Partners Investment Advisory sold 110 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $7K.
- Steward Partners Investment Advisory first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 21 quarters.
- Steward Partners Investment Advisory's Global Blood Therapeutics, Inc. position peaked at $68K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.